Male Hypogonadism

Swaytha Yalamanchi, M.D., Amin Sabet, M.D.
Male Hypogonadism is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

Coronavirus COVID-19 (SARS-CoV-2)Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 PandemicSuicide Risk in the COVID-19 Pandemic

Moderna COVID-19 VaccineModerna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19Managing Stress and Coping with COVID-19

Managing Sleep Problems during COVID-19Managing Sleep Problems during COVID-19

-- The first section of this topic is shown below --

DEFINITION

  • Male hypogonadism is a clinical syndrome that results from the failure of the testes to produce physiologic testosterone levels and/or normal number of spermatazoa as a result of disruption of one or more levels of the hypothalamic-pituitary-testicular axis[4].
  • Classified as primary (resulting from testicular disease), secondary (resulting from pituitary and/or hypothalamic disease), or combined primary/secondary.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

DEFINITION

  • Male hypogonadism is a clinical syndrome that results from the failure of the testes to produce physiologic testosterone levels and/or normal number of spermatazoa as a result of disruption of one or more levels of the hypothalamic-pituitary-testicular axis[4].
  • Classified as primary (resulting from testicular disease), secondary (resulting from pituitary and/or hypothalamic disease), or combined primary/secondary.

There's more to see -- the rest of this entry is available only to subscribers.